BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 29, Issue 37
This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (12425)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-2) series.
Item 
Count 
PDF155
WORD43
HTML9089
Figures (1-6)508
Tables (1-2)401
 Sum=10196
Featured Article
The chart showing Browse series, Download series.
Item 
Count 
Browse304
Download658
 Sum=962
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse237
Download581
 Sum=818
Oct 7, 2023 (publication date) through Apr 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Zhu K, Kakkar R, Chahal D, Yoshida EM, Hussaini T. Efficacy and safety of semaglutide in non-alcoholic fatty liver disease. World J Gastroenterol 2023; 29(37): 5327-5338 [PMID: 37899788 DOI: 10.3748/wjg.v29.i37.5327]
URL: https://www.wjgnet.com/1007-9327/full/v29/i37/5327.htm
Number Citing Articles
1
Antonio Saviano, Natascha Roehlen, Thomas F. Baumert. Tight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular Carcinoma. Seminars in Liver Disease 2024; 44(02): 180 doi: 10.1055/s-0044-1785646
2
Giovanna McGinty, Robert Przemioslo. Effects of excess high-normal alanine aminotransferase levels in relation to new-onset metabolic dysfunction-associated fatty liver disease: Clinical implications. World Journal of Gastroenterology 2024; 30(27): 3264-3267 doi: 10.3748/wjg.v30.i27.3264
3
Rong Ren, Yanxia Pei, Lufei Kong, Yixin Shi. The effect of semaglutide combined with metformin on liver inflammation and pancreatic beta-cell function in patients with type 2 diabetes and non-alcoholic fatty liver disease. Journal of Diabetes and its Complications 2025; 39(2): 108932 doi: 10.1016/j.jdiacomp.2024.108932
4
Mohit Kehar, Samar H. Ibrahim, Charina M. Ramirez, Saista Asif Amin, Tamir Diamond, Saeed Mohammad. Utilization and perspectives of weight loss medications in pediatric metabolic dysfunction‐associated steatotic liver disease. Journal of Pediatric Gastroenterology and Nutrition 2024; 79(3): 661 doi: 10.1002/jpn3.12236
5
Matthew Peverelle, Jonathan Ng, James Peverelle, Ryan D. Hirsch, Adam Testro. Liver decompensation after rapid weight loss from semaglutide in a patient with non-alcoholic steatohepatitis -associated cirrhosis. World Journal of Gastroenterology 2023; 29(47): 6165-6167 doi: 10.3748/wjg.v29.i47.6165
6
Fabiana Dolovitsch de Oliveira, Samira Mohamad Khalil, Emmily Daiane Buarque de Santana Sato, Matheus Henrique Gonçalves de Souza, Gilmara Coelho Meine. Efficacy and Safety of Fibroblast Growth Factor 21 Analogues for Metabolic Dysfunction-Associated Steatohepatitis: A Systematic Review and Meta-Analysis. Annals of Nutrition and Metabolism 2024; : 1 doi: 10.1159/000541583
7
Hong-Tai Tzeng, Wei-Chia Lee. Impact of Transgenerational Nutrition on Nonalcoholic Fatty Liver Disease Development: Interplay between Gut Microbiota, Epigenetics and Immunity. Nutrients 2024; 16(9): 1388 doi: 10.3390/nu16091388
8
Moaz Safwan, Mariam Safwan Bourgleh, Shahad Abdullah Alotaibi, Eman Alotaibi, Abdulsalam Al-Ruqi, Fathiya El Raeya. Gastrointestinal safety of semaglutide and tirzepatide vs. placebo in obese individuals without diabetes: a systematic review and meta analysis. Annals of Saudi Medicine 2025; 45(2): 129 doi: 10.5144/0256-4947.2025.129
9
Farah Khaznadar, Omar Khaznadar, Ana Petrovic, Marija Hefer, Fabian Gjoni, Stefan Gjoni, Justinija Steiner, Martina Smolic, Kristina Bojanic. MAFLD Pandemic: Updates in Pharmacotherapeutic Approach Development. Current Issues in Molecular Biology 2024; 46(7): 6300 doi: 10.3390/cimb46070376
10
Klaudia Nowak, Krzysztof Łupina, Anna Romac, Aleksandra Kalisz, Łucja Ilkiewicz, Jakub Janczura. Therapeutic Potential of GLP-1 Receptor Agonists in Metabolic Associated Steatotic Liver Disease. Annals of Pharmacotherapy 2025;  doi: 10.1177/10600280251322002
11
V. T. Ivashkin, O. M. Drapkina, M. V. Maevskaya, K. L. Raikhelson, S. V. Okovityi, M. S. Zharkova, V. R. Grechishnikova, D. I. Abdulganieva, S. A. Alekseenko, M. D. Ardatskaya, I. G. Bakulin, N. V. Bakulina, P. O. Bogomolov, V. V. Breder, E. V. Vinnitskaya, N. I. Geyvandova, E. V. Golovanova, V. B. Grinevich, V. L. Doshchitsin, E. N. Dudinskaya, E. V. Ershova, K. B. Kodzoeva, I. V. Kozlova, K. A. Komshilova, Yu. V. Konev, N. V. Korochanskaya, Yu. V. Kotovskaya, Yu. A. Kravchuk, I. D. Loranskaya, I. V. Maev, A. I. Martynov, S. N. Mekhtiev, E. E. Mishina, M. Yu. Nadinskaia, I. G. Nikitin, M. F. Osipenko, O. D. Ostroumova, Ch. S. Pavlov, N. V. Pogosova, V. G. Radchenko, G. E. Roytberg, R. G. Saifutdinov, A. A. Samsonov, P. V. Seliverstov, S. I. Sitkin, L. V. Tarasova, A. I. Tarzimanova, O. N. Tkacheva, E. I. Tkachenko, E. A. Troshina, S. V. Turkina, Yu. P. Uspenskiy, Yu. A. Fominykh, O. V. Khlynova, Yu. V. Tsyganova, M. Sh. Shamkhalova, O. O. Sharkhun, M. V. Shestakova. Clinical Guidelines of the Russian Society for the Study of the Liver, Russian Gastroenterological Association, Russian Society for the Prevention of Non-Communicable Diseases, Russian Association of Endocrinologists, Russian Scientific Medical Society of Therapists, National Society of Preventive Cardiology, Russian Association of Gerontologists and Geriatricians on Non-Alcoholic Fatty Liver Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2025; 35(1): 94 doi: 10.22416/1382-4376-2025-35-1-94-152
12
Mohamed Mahmoud Marey, Mohamed Belal, Abdelaziz A. Awad, Eslam Mohammed Rabea, Malak A. Hassan, Ahmed W. Abbas, Abdulqadir J. Nashwan. Efficacy and safety of aldafermin in non-alcoholic steatohepatitis: A systematic review and meta-analysis of randomized controlled trials. Clinics and Research in Hepatology and Gastroenterology 2024; 48(6): 102357 doi: 10.1016/j.clinre.2024.102357
13
Ermina Stratina, Carol Stanciu, Robert Nastasa, Sebastian Zenovia, Remus Stafie, Adrian Rotaru, Tudor Cuciureanu, Cristina Muzica, Catalin Sfarti, Irina Girleanu, Horia Minea, Oana Petrea, Laura Huiban, Stefan Chiriac, Ana-Maria Singeap, Oana Vlad, Camelia Cojocariu, Anca Trifan. New Insights on Using Oral Semaglutide versus Dapagliflozin in Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease. Diagnostics 2024; 14(14): 1475 doi: 10.3390/diagnostics14141475
14
Sultan Alfawaz, Abdulhadi Burzangi , Ahmed Esmat. Mechanisms of Non-alcoholic Fatty Liver Disease and Beneficial Effects of Semaglutide: A Review. Cureus 2024;  doi: 10.7759/cureus.67080
15
Fatima Ali Raza, Rafiya Altaf, Talha Bashir, Fatima Asghar, Rabiya Altaf, Sohaib Tousif, Aman Goyal, Aisha Mohammed, Mahnoor Faisal Mohammad, Mahfuza Anan, Sajjad Ali. Effect of GLP-1 receptor agonists on weight and cardiovascular outcomes: A review. Medicine 2024; 103(44): e40364 doi: 10.1097/MD.0000000000040364
16
Yue-Hua Yin, Li-Xuan Sang, Bing Chang. Potential therapeutic targets for nonalcoholic fatty liver disease: Glucagon-like peptide 1. World Journal of Gastroenterology 2023; 29(48): 6235-6238 doi: 10.3748/wjg.v29.i48.6235
17
Tereza Dusilová, Jan Kovář, Ivana Laňková, Lenka Thieme, Monika Hubáčková, Petr Šedivý, Dita Pajuelo, Martin Burian, Monika Dezortová, Denisa Miklánková, Hana Malínská, Petra Svobodová Šťastná, Rudolf Poledne, Milan Hájek, Martin Haluzík. Semaglutide Treatment Effects on Liver Fat Content in Obese Subjects with Metabolic-Associated Steatotic Liver Disease (MASLD). Journal of Clinical Medicine 2024; 13(20): 6100 doi: 10.3390/jcm13206100
18
Kathryn J Potter, Jackie Phinney, Tasha Kulai, Vicki Munro. Effects of GLP-1 receptor agonist therapy on resolution of steatohepatitis in non-alcoholic fatty liver disease: a systematic review and meta-analysis. Journal of the Canadian Association of Gastroenterology 2025; 8(2): 47 doi: 10.1093/jcag/gwae057
19
Megan O. Bensignor, Silva Arslanian, Mary Ellen Vajravelu. Semaglutide for management of obesity in adolescents: efficacy, safety, and considerations for clinical practice. Current Opinion in Pediatrics 2024; 36(4): 449 doi: 10.1097/MOP.0000000000001365
20
Samira Mohamad Khalil, Matheus Henrique Gonçalves de Souza, Fabiana Dolovitsch de Oliveira, Emmily Daiane Buarque de Santana Sato, Gilmara Coelho Meine. Efficacy and safety of aldafermin for the treatment of metabolic dysfunction-associated steatohepatitis: A systematic review and meta-analysis. Clinics and Research in Hepatology and Gastroenterology 2025; 49(5): 102579 doi: 10.1016/j.clinre.2025.102579
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345